\-\ Texto\\:\\ \ \(0\)\
\-\ pain\\ with\\ deep\\ palpation\\ of\\ right\\ hip\\ region\\.\ \(0\)\
\-\ no\\ lab\\ tests\\ performed\\.\ \(0\)\
\-\ 1\\.\\ conservative\\ watching\\ and\\ waiting\\.\ \(0\)\
\-\ 2\\.\\ orthopedic\\ treatment\\ options\\:\ \(0\)\
\-\ internal\\ fixation\\ with\\ intramedullary\\ nails\\ \ \(0\)\
\-\ provides\\ stabilization\\ of\\ extensively\\ affected\\ bones\\ \ \(1\)\
\-\ prevents\\ further\\ fractures\\ and\\ major\\ deformities\\ \ \(1\)\
\-\ curettage\\,\\ and\\ bone\\ grafting\\.\ \(1\)\
\-\ 3\\.\\ medical\\ management\\:\\ \ \(0\)\
\-\ intravenous\\ infusions\\ with\\ the\\ bisphosphonate\\ compound\\:\\ i\\.e\\.\\ alendronate\\,\\ pamidronate\\.\ \(0\)\
\-\ these\\ drugs\\ alter\\ bone\\ resorption\\ and\\ may\\ help\\ the\\ pain\\ of\\ fibrous\\ dysplasia\\ \\ and\\ also\\ may\\ strengthen\\ the\\ bone\\.\ \(0\)\
\-\ well\\ circumscribed\\ lytic\\ lesion\ \(1\)\
\-\ large\\ lesion\\:\\ 10\\ cm\\ x\\ 3\\ cm\ \(0\)\
\-\ \\"ground\\ glass\\"\\ ppacity\\ on\\ plain\\ radiographs\ \(0\)\
\-\ fibrous\\ dysplasia\\ of\\ the\\ hip\ \(0\)\
\-\ unicameral\\ bone\\ cyst\ \(4\)\
\-\ eosinophilic\\ granuloma\\ \\(langerhan\\ histiocytosis\\)\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ less\\ likely\\ dd\ \(0\)\
\-\ hemangioma\\ of\\ the\\ bone\ \(0\)\
\-\ primary\\ hyperparathyroidism\\ \ \(2\)\
\-\ metastases\\ \\(at\\ this\\ age\\,\\ neuroblastoma\\)\ \(0\)\
\-\ 8\\ y\\.o\\.\\ boy\\ with\\ pain\\ in\\ the\\ right\\ hip\ \(1\)\
\-\ no\\ other\\ pmhx\\ given\ \(0\)\
\-\ this\\ patient\\&\\#39\\;s\\ pain\\ had\\ been\\ increasing\\ and\\ the\\ lesion\\ had\\ grown\\ since\\ the\\ original\\ diagnosis\\.\\ his\\ orthopedic\\ surgeon\\ was\\ opting\\ for\\ curettage\\ due\\ to\\ patients\\ increase\\ in\\ complaints\\.\\ at\\ the\\ time\\ of\\ case\\ submission\\,\\ no\\ definite\\ surgical\\ planning\\ had\\ been\\ performed\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bone\\:\\ 0\\.2361207206230539\ \(0\)\
\-\ fibrous\\:\\ 0\\.20169612066746562\ \(0\)\
\-\ hip\\:\\ 0\\.19945543050296963\ \(0\)\
\-\ dysplasia\\:\\ 0\\.19886300272129734\ \(0\)\
\-\ curettage\\:\\ 0\\.19084924568552397\ \(0\)\
\-\ the\\:\\ 0\\.15542798159587076\ \(0\)\
\-\ orthopedic\\:\\ 0\\.15360891345361133\ \(0\)\
\-\ ppacity\\:\\ 0\\.13841160771507718\ \(0\)\
\-\ alendronate\\:\\ 0\\.13225968043255784\ \(0\)\
\-\ opting\\:\\ 0\\.13225968043255784\ \(0\)\
\-\ had\\:\\ 0\\.12936653706513837\ \(0\)\
\-\ pamidronate\\:\\ 0\\.1278948185620373\ \(0\)\
\-\ watching\\:\\ 0\\.1245091686656671\ \(0\)\
\-\ nails\\:\\ 0\\.1245091686656671\ \(0\)\
\-\ lesion\\:\\ 0\\.12448137067161255\ \(0\)\
\-\ pain\\:\\ 0\\.12388248816849401\ \(0\)\
\-\ infusions\\:\\ 0\\.12174289127951794\ \(0\)\
\-\ bisphosphonate\\:\\ 0\\.12174289127951794\ \(0\)\
\-\ dd\\:\\ 0\\.12174289127951794\ \(0\)\
\-\ extensively\\:\\ 0\\.1155909639969986\ \(0\)\
\-\ alter\\:\\ 0\\.11254628394554911\ \(0\)\
\-\ prevents\\:\\ 0\\.11122610212647804\ \(0\)\
\-\ compound\\:\\ 0\\.11001165257889284\ \(0\)\
\-\ waiting\\:\\ 0\\.10888724792204861\ \(0\)\
\-\ grown\\:\\ 0\\.10888724792204861\ \(0\)\
\-\ and\\:\\ 0\\.10730645673525518\ \(0\)\
\-\ strengthen\\:\\ 0\\.1068612402559575\ \(0\)\
\-\ submission\\:\\ 0\\.10594141199580188\ \(0\)\
\-\ langerhan\\:\\ 0\\.1050741748439587\ \(0\)\
\-\ unicameral\\:\\ 0\\.10273532063952927\ \(0\)\
\-\ performed\\:\\ 0\\.10240601902741323\ \(0\)\
\-\ of\\:\\ 0\\.10162420906236368\ \(0\)\
\-\ been\\:\\ 0\\.10084952200292012\ \(0\)\
\-\ grafting\\:\\ 0\\.10008994046321708\ \(0\)\
\-\ cm\\:\\ 0\\.09941280212148629\ \(0\)\
\-\ stabilization\\:\\ 0\\.09837045876900871\ \(0\)\
\-\ planning\\:\\ 0\\.09837045876900871\ \(0\)\
\-\ resorption\\:\\ 0\\.09732366307706794\ \(0\)\
\-\ intramedullary\\:\\ 0\\.09498480887263851\ \(0\)\
\-\ provides\\:\\ 0\\.09498480887263851\ \(0\)\
\-\ original\\:\\ 0\\.09186151455434337\ \(0\)\
\-\ pmhx\\:\\ 0\\.09151270563946931\ \(0\)\
\-\ deformities\\:\\ 0\\.08785366961596881\ \(0\)\
\-\ may\\:\\ 0\\.0871089475564476\ \(0\)\
\-\ glass\\:\\ 0\\.08706188025538293\ \(0\)\
\-\ histiocytosis\\:\\ 0\\.08680687392402804\ \(0\)\
\-\ drugs\\:\\ 0\\.086556082766907\ \(0\)\
\-\ definite\\:\\ 0\\.08513261586853821\ \(0\)\
\-\ no\\:\\ 0\\.08443480808747002\ \(0\)\
\-\ ground\\:\\ 0\\.0842528030677719\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.0842528030677719\ \(0\)\
\-\ surgeon\\:\\ 0\\.0840405965378789\ \(0\)\
\-\ tests\\:\\ 0\\.0828261469902937\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.08244201205350749\ \(0\)\
\-\ fixation\\:\\ 0\\.08082447376335183\ \(0\)\
\-\ help\\:\\ 0\\.0795185050783948\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.0795185050783948\ \(0\)\
\-\ intravenous\\:\\ 0\\.07890539056766732\ \(0\)\
\-\ granuloma\\:\\ 0\\.07831609243707925\ \(0\)\
\-\ lab\\:\\ 0\\.07817227600905158\ \(0\)\
\-\ options\\:\\ 0\\.07802980998995694\ \(0\)\
\-\ major\\:\\ 0\\.07567071226076708\ \(0\)\
\-\ lytic\\:\\ 0\\.07290443487461792\ \(0\)\
\-\ hemangioma\\:\\ 0\\.07280362042027051\ \(0\)\
\-\ 39\\:\\ 0\\.07192522290046759\ \(0\)\
\-\ complaints\\:\\ 0\\.07127553565577184\ \(0\)\
\-\ affected\\:\\ 0\\.07118495318040957\ \(0\)\
\-\ metastases\\:\\ 0\\.06997050363282435\ \(0\)\
\-\ bones\\:\\ 0\\.06964065326041097\ \(0\)\
\-\ increase\\:\\ 0\\.06947837877711759\ \(0\)\
\-\ increasing\\:\\ 0\\.06816492385665246\ \(0\)\
\-\ with\\:\\ 0\\.06778995300204183\ \(0\)\
\-\ deep\\:\\ 0\\.06737188010231966\ \(0\)\
\-\ circumscribed\\:\\ 0\\.06702466770657763\ \(0\)\
\-\ conservative\\:\\ 0\\.06682009130988902\ \(0\)\
\-\ at\\:\\ 0\\.06538173815636929\ \(0\)\
\-\ fractures\\:\\ 0\\.06398623020594944\ \(0\)\
\-\ management\\:\\ 0\\.06393013949675487\ \(0\)\
\-\ since\\:\\ 0\\.06269417169346078\ \(0\)\
\-\ given\\:\\ 0\\.05953730984032965\ \(0\)\
\-\ this\\:\\ 0\\.059479983220508625\ \(0\)\
\-\ boy\\:\\ 0\\.05920565686371346\ \(0\)\
\-\ less\\:\\ 0\\.05888109861537087\ \(0\)\
\-\ palpation\\:\\ 0\\.05836806468323754\ \(0\)\
\-\ internal\\:\\ 0\\.05832930982294023\ \(0\)\
\-\ right\\:\\ 0\\.05738952843687942\ \(0\)\
\-\ plain\\:\\ 0\\.057102955590901866\ \(0\)\
\-\ further\\:\\ 0\\.05637118826364531\ \(0\)\
\-\ radiographs\\:\\ 0\\.056134903984711264\ \(0\)\
\-\ medical\\:\\ 0\\.05500571530778731\ \(0\)\
\-\ age\\:\\ 0\\.05433667820475272\ \(0\)\
\-\ primary\\:\\ 0\\.05321864989578851\ \(0\)\
\-\ his\\:\\ 0\\.052490229078759214\ \(0\)\
\-\ region\\:\\ 0\\.05177004211419072\ \(0\)\
\-\ likely\\:\\ 0\\.05171988497906818\ \(0\)\
\-\ time\\:\\ 0\\.051300113970323254\ \(0\)\
\-\ 10\\:\\ 0\\.050609794020980994\ \(0\)\
\-\ cyst\\:\\ 0\\.049927256773402234\ \(0\)\
\-\ due\\:\\ 0\\.04975031576450361\ \(0\)\
\-\ these\\:\\ 0\\.04887452968202815\ \(0\)\
\-\ patients\\:\\ 0\\.04868886771067356\ \(0\)\
\-\ other\\:\\ 0\\.04494658234564672\ \(0\)\
\-\ diagnosis\\:\\ 0\\.0448666847436536\ \(0\)\
\-\ case\\:\\ 0\\.04348156388512497\ \(0\)\
\-\ large\\:\\ 0\\.04336563193955899\ \(0\)\
\-\ in\\:\\ 0\\.043061449306977896\ \(0\)\
\-\ surgical\\:\\ 0\\.04206591529853986\ \(0\)\
\-\ well\\:\\ 0\\.04190772947412758\ \(0\)\
\-\ treatment\\:\\ 0\\.04122815366749121\ \(0\)\
\-\ also\\:\\ 0\\.04071043827412001\ \(0\)\
\-\ was\\:\\ 0\\.030163382764430445\ \(0\)\
\-\ patient\\:\\ 0\\.028150230923489648\ \(0\)\
\-\ for\\:\\ 0\\.026232511069025348\ \(0\)\
\-\ on\\:\\ 0\\.026139456379564028\ \(0\)\
\-\ to\\:\\ 0\\.021637223020383043\ \(0\)\
